EP Patent

EP1901793A1 — Inhaler device

Assigned to Cipla Ltd · Expires 2008-03-26 · 18y expired

What this patent protects

An inhaler device (2) is for the inhalation of particulate substances is provided. The device comprises a housing (5) having first and second openings, a first air passageway (11) being defined through said housing between said first and second openings, an extraction member (40)…

USPTO Abstract

An inhaler device (2) is for the inhalation of particulate substances is provided. The device comprises a housing (5) having first and second openings, a first air passageway (11) being defined through said housing between said first and second openings, an extraction member (40) extending from said housing and having a second air passageway (46) formed therein, and an airflow directing means (16) proximate one of said first and second openings.

Drugs covered by this patent

Patent Metadata

Patent number
EP1901793A1
Jurisdiction
EP
Classification
—
Expires
2008-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Cipla Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.